The aim of GWAS (Genome wide association studies) is to locate chromosome regions containing the genes influencing the risk of disease, when applied to the study of the human genome. Unique articular genes can be identified in these regions; especially mutant alleles that intensify disease risk are to be sequenced. So far, the recognition of these alleles occasionally led to a new therapeutic strategy, but more frequently the identification of disease alleles is the only outcome. a. From a physician’s perspective, describe the importance of identification of these alleles that increase the risk of a specific disease. b. Explain the importance of identifying alleles that increase disease risk for a person who is currently free of the disease but what about the persons having pre-disposal of this disease that is running in the family. c. Describe the personal or ethical issues occured from GWAS, might be of concern to physicians or to those who may carry an allele that increases the risk of disease. Introduction: GWAS is designed for the detection and location of the genes that influence the appearance of the trait by multiple genes. These multiple genes responsible for a particular trait are dispersed throughout the genome. Hence, the GWAS helps to locate the particular gene in the genome. GWAS does not create any gene map of a chromosome rather it finds the association of traits and the groups of alleles to locate these influencing genes on different chromosomes. In the GWAS, the term association refers to the trait co-occurs with group of alleles more often than expected. The GWAS connects the presence of DNA marker having sequence variation with quantitative trait loci (QTL) affecting the particular phenotype . GWAS scans the entire genome to locate the QTL by statistical analysis.

Question

Want to see the full answer?

Answer 1

Question

Chapter 19, Problem 21P

Summary Introduction

To analyze:

The aim of GWAS (Genome wide association studies) is to locate chromosome regions containing the genes influencing the risk of disease, when applied to the study of the human genome. Unique articular genes can be identified in these regions; especially mutant alleles that intensify disease risk are to be sequenced. So far, the recognition of these alleles occasionally led to a new therapeutic strategy, but more frequently the identification of disease alleles is the only outcome.

a. From a physician’s perspective, describe the importance of identification of these alleles that increase the risk of a specific disease.

b. Explain the importance of identifying alleles that increase disease risk for a person who is currently free of the disease but what about the persons having pre-disposal of this disease that is running in the family.

c. Describe the personal or ethical issues occured from GWAS, might be of concern to physicians or to those who may carry an allele that increases the risk of disease.

Introduction:

GWAS is designed for the detection and location of the genes that influence the appearance of the trait by multiple genes. These multiple genes responsible for a particular trait are dispersed throughout the genome. Hence, the GWAS helps to locate the particular gene in the genome.

GWAS does not create any gene map of a chromosome rather it finds the association of traits and the groups of alleles to locate these influencing genes on different chromosomes.

In the GWAS, the term association refers to the trait co-occurs with group of alleles more often than expected.

The GWAS connects the presence of DNA marker having sequence variation with quantitative trait loci (QTL) affecting the particular phenotype. GWAS scans the entire genome to locate the QTL by statistical analysis.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

Pinpointing a disease gene requires a combination of approaches. Mutations in the XIAP gene are known to cause a serious condition called X-linked lymphoproliferative disease (XLPD). In the case of XLPD, in which the blood contains too many lymphocytes (white blood cells of the immune system), crowding out the oxygen-carrying red blood cells and damaging the liver. When compairing the XIAP amino acid sequence of one affected patient to other human and animal standard RefSeq, the patient has an amino acid substitution at position 203, from cystenine (C) to tyrosing (Y). This evolutionary conservation suggests Group of answer choices that the standard RefSeq does not provide enough information to determine a possible cause of XIAP function. mutations in the XIAP gene and XLPD are not associated. that the mutation in the affected patient has no impact on XIAP function. that the mutation in the affected patient might alter XIAP function.

If human genetics is leading toward preventive medicine, give the most significant expectations regarding gene therapy (please explain in detail).

While a stem cell transplant from an unaffected donor is currently the only cure for DBA, genome-editing technologies may one day enable the correction of a mutation in a patient’s own bone marrow stem cells. However, what specific information would be needed, beyond a symptom-based diagnosis of DBA, in order to accomplish this?